Listed

Clorox Co: Form 10-Q for the period ended Dec 31, 2024

Filed with the SEC on Feb 3, 2025 and accepted by EDGAR at Feb 3, 2025, 16:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-10-01 to 2024-12-31$1.69bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2024-07-01 to 2024-12-31$3.45bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2024-10-01 to 2024-12-31$948.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2024-07-01 to 2024-12-31$1.90bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2024-10-01 to 2024-12-31$738.0mus-gaap:GrossProfit
Gross profit6 months2024-07-01 to 2024-12-31$1.54bnus-gaap:GrossProfit
Research and development3 months2024-10-01 to 2024-12-31$31.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2024-07-01 to 2024-12-31$62.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2024-10-01 to 2024-12-31$280.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2024-07-01 to 2024-12-31$561.0mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2024-10-01 to 2024-12-31$22.0mus-gaap:InterestExpense
Interest expense6 months2024-07-01 to 2024-12-31$43.0mus-gaap:InterestExpense
Income tax3 months2024-10-01 to 2024-12-31$43.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2024-07-01 to 2024-12-31$117.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-10-01 to 2024-12-31$193.0mus-gaap:NetIncomeLoss
Net income6 months2024-07-01 to 2024-12-31$292.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-10-01 to 2024-12-31$1.54us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2024-07-01 to 2024-12-31$2.34us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-10-01 to 2024-12-31$1.55us-gaap:EarningsPerShareBasic
Basic EPS6 months2024-07-01 to 2024-12-31$2.36us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-10-01 to 2024-12-31124,662,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2024-07-01 to 2024-12-31124,669,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2024-07-01 to 2024-12-31$401.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2024-07-01 to 2024-12-31$92.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2024-07-01 to 2024-12-31$302.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2024-07-01 to 2024-12-31$257.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2024-12-31$290.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-12-31$1.63bnus-gaap:AssetsCurrent
Total assetsAt period end2024-12-31$5.58bnus-gaap:Assets
Current liabilitiesAt period end2024-12-31$1.73bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-12-31$5.46bnus-gaap:Liabilities
Long-term debtAt period end2024-12-31$2.48bnus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2024-12-31$189.0mus-gaap:CommercialPaper
Shareholders' equityAt period end2024-12-31−$41.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000021076-25-000013. Last ingested by Listed: Nov 5, 2026, 18:00 ET. Listed shows no prices and gives no investment advice.